Mitsuhiro Yamamura Selected Research

Edaravone

12/2017	Pretreatment with the Free Radical Scavenger Edaravone Mitigates Kidney Glycogen Depletion and Neutrophil Infiltration after Leg Ischemia in a Rat Model: A Pilot Study.
9/2014	Edaravone injected at the start of reperfusion suppresses myonephropathic metabolic syndrome in rats.
12/2013	Edaravone Suppresses Reperfusion Injury following Leg Ischemia in Rats: A Transmission Electron Microscopic Study.
1/2010	Edaravone reduces mitochondrial damage due to reperfusion injury following leg ischemia in rats.
1/2010	Edaravone protects against tissue damage in the lung and kidney induced by myonephropathic metabolic syndrome.
1/2008	Edaravone suppresses endothelial cell injury in vein grafts of a rat model.
1/2007	Suppression of postoperative intimal hyperplasia of vein grafts with edaravone in rat models - a scanning electron microscope study.
1/2007	Edaravone suppresses postoperative reperfusion injury in rat lower extremity: An immunohistological study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mitsuhiro Yamamura Research Topics

Disease

5	Reperfusion Injury 09/2014 - 01/2007
3	Stroke (Strokes) 05/2021 - 10/2016
3	Ischemia 12/2017 - 01/2010
2	Aortic Aneurysm (Aneurysm, Aortic) 05/2022 - 02/2021
2	Hemorrhage 12/2021 - 01/2003
2	Endoleak 12/2020 - 03/2019
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2014 - 01/2010
2	Hyperplasia 01/2008 - 01/2007
2	Endocarditis 04/2003 - 01/2003
1	Atrial Fibrillation 05/2021
1	Cardiac Tamponade 02/2021
1	Cysts 01/2021
1	Left Ventricular Outflow Obstruction 01/2021
1	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 03/2017
1	Hemolytic Anemia 03/2017
1	Nephrotic Syndrome (Syndrome, Nephrotic) 09/2015
1	Myxoma (Myxomas) 09/2014
1	Myocardial Infarction 04/2012
1	Brain Infarction 04/2012
1	Heart Arrest (Cardiac Arrest) 08/2010
1	Esophageal Neoplasms (Esophageal Cancer) 10/2009
1	Aortic Valve Stenosis (Aortic Stenosis) 10/2009
1	Diabetic Nephropathies (Diabetic Nephropathy) 05/2009
1	Glomerulonephritis 05/2009
1	Aortic Dissection 02/2008
1	Tetany (Spasmophilia) 11/2006
1	Hypoparathyroidism 11/2006
1	Aortic Valve Insufficiency (Aortic Regurgitation) 04/2003
1	Abscess 04/2003
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2003
1	Thromboembolism 01/2003

Drug/Important Bio-Agent (IBA)

8	EdaravoneIBA 12/2017 - 01/2007
7	Free Radical ScavengersIBA 12/2017 - 01/2007
3	GlycogenIBA 12/2017 - 01/2010
3	Free RadicalsIBA 12/2013 - 01/2010
2	Biological ProductsIBA 04/2003 - 01/2003
1	TitaniumIBA 02/2021
1	Pharmaceutical PreparationsIBA 03/2017
1	Dihydrotachysterol (AT 10)IBA 02/2008
1	Electron Transport Complex IV (Cytochrome c Oxidase)IBA 01/2007
1	Coloring Agents (Dyes)IBA 01/2007
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 11/2006
1	Formaldehyde (Formol)FDA Link 04/2003

Therapy/Procedure

4	Endovascular Aneurysm Repair 05/2022 - 03/2019
4	Thoracotomy 12/2021 - 04/2012
3	Cardiopulmonary Bypass (Heart-Lung Bypass) 01/2021 - 10/2016
1	Sutures (Suture) 12/2021
1	Maze Procedure 05/2021
1	Traction 01/2021
1	Endovascular Procedures 10/2016
1	Critical Care (Surgical Intensive Care) 09/2015
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 09/2014
1	Sternotomy 08/2010
1	Esophagectomy 10/2009
1	Renal Dialysis (Hemodialysis) 05/2009
1	Thyroidectomy 11/2006